Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Inventory Average (2021 - 2026)

GeneDx Holdings has reported Inventory Average over the past 6 years, most recently at $13.1 million for Q1 2026.

  • Quarterly Inventory Average rose 12.35% to $13.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.1 million through Mar 2026, up 12.35% year-over-year, with the annual reading at $12.3 million for FY2025, 26.63% up from the prior year.
  • Inventory Average was $13.1 million for Q1 2026 at GeneDx Holdings, up from $12.3 million in the prior quarter.
  • Over five years, Inventory Average peaked at $42.9 million in Q3 2022 and troughed at $9.1 million in Q4 2023.
  • The 5-year median for Inventory Average is $11.9 million (2023), against an average of $17.2 million.
  • Year-over-year, Inventory Average skyrocketed 42.24% in 2022 and then tumbled 75.66% in 2023.
  • A 5-year view of Inventory Average shows it stood at $28.9 million in 2022, then crashed by 68.66% to $9.1 million in 2023, then increased by 18.17% to $10.7 million in 2024, then increased by 14.47% to $12.3 million in 2025, then increased by 6.82% to $13.1 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Inventory Average are $13.1 million (Q1 2026), $12.3 million (Q4 2025), and $11.3 million (Q3 2025).